Yuyue Medical gains approval for glucose monitoring system

Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) announced that its subsidiary, Jiangsu Yuyue Kailite Biotechnology, has received a medical device registration certificate from the National Medical Products Administration for its continuous glucose monitoring (CGM) system. The CGM system, registered under certificate number 国械注准20253070727, is classified as a Class III medical device and will be valid from April 1, 2025, to March 31, 2030. The product line includes several models, such as Anytime 5 and Anytime 5Pro. The CGM system is designed for continuous or regular monitoring of interstitial fluid glucose levels in adult patients with diabetes. It aims to provide real-time glucose values without requiring user calibration, with a maximum usage duration of 16 days per sensor.